Dublin Cardiovascular Research Forum - Dr. Alexander Lyon

Cardiovascular Research Institute Dublin at Mater Private Network is pleased to advise the Winter 2025 schedule for the Dublin Cardiovascular Research Forum.

For further information visit: www.cvridublin.ie/education-and-publication/dublin-cardiovascular-research-forum/future-events

Speaker: Dr. Alexander Lyon, Consultant Cardiologist and Director of the new Cardio-Oncology Centre of Excellence at the Royal Brompton Hospital.

Title: "Cardiovascular complications of Immune Checkpoint Inhibitors in Cancer patients."

Alex trained at Oxford University where he was awarded a first class degree and a clinical scholarship. Alex studied for his PhD in gene therapy for heart failure at Imperial College. His clinical interests are in the field of cardio-oncology (cardiovascular disease in cancer patients), heart failure, complex hypertension, Takotsubo syndrome and the effects of major stresses of the heart, and gene therapy for chronic heart failure. 

Alex has been the clinical lead for the Cardio-Oncology service at the Royal Brompton Hospital since 2011, specialising in surveillance and cardioprotection from modern cancer drugs, risk stratification and treatment of all cardiac complications of cancer treatment. The service was recently awarded a Gold Cardio-Oncology Centre of Excellence award from the International Cardio-Oncology Society in 2022.

Alex is a co-chair of the first European Society of Cardiology (ESC) Cardio-Oncology Guidelines for the management of cardiovascular disease in cancer patients and survivors. He is also a co-author of the 2021 BSE-BCOS guideline on echocardiography in cancer patients and the 2022 ESMO guideline on the diagnosis and management of immunotherapy-related toxicities.

Alex is co-organiser of the first ESC Cardio-Oncology Conference in 2025.

Alex is a past chair of the ESC Council of Cardio-Oncology (2022-2024), the past president of the British Cardio-Oncology Society, a board member of International Cardio-Oncology Society (ICOS), and he is the cardiology advisor to the charity Macmillan Cancer. Alex is a co-investigator of the first Leducq Cardio-Oncology Transatlantic Research Network funded from 2020-2025 ($6M).

Alex has published over 240 scientific papers in peer-reviewed journals and Alex is a deputy editor of the European Heart Journal. His H-index is 69.

To receive a registration link please email the CVRI Dublin team at cvri@materprivate.ie